Amdocs Limited (NASDAQ:DOX – Get Free Report) insider Shimie Hortig sold 7,255 shares of the company’s stock in a transaction dated Sunday, November 15th. The stock was sold at an average price of $43.34, for a total transaction of $314,431.70. Following the completion of the transaction, the insider owned 178,416 shares in the company, valued at $7,732,549.44. This represents a 3.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Shimie Hortig also recently made the following trade(s):
- On Saturday, November 14th, Shimie Hortig sold 5,642 shares of Amdocs stock. The stock was sold at an average price of $43.34, for a total transaction of $244,524.28.
- On Wednesday, November 11th, Shimie Hortig sold 1,733 shares of Amdocs stock. The shares were sold at an average price of $43.14, for a total transaction of $74,761.62.
- On Tuesday, November 10th, Shimie Hortig sold 7,264 shares of Amdocs stock. The shares were sold at an average price of $42.18, for a total value of $306,395.52.
Amdocs Trading Down 2.6%
Shares of NASDAQ DOX traded down $1.11 during trading hours on Thursday, reaching $41.17. The stock had a trading volume of 653,627 shares, compared to its average volume of 1,329,487. Amdocs Limited has a 52-week low of $39.96 and a 52-week high of $84.95. The firm has a market cap of $4.44 billion, a price-to-earnings ratio of 8.82, a P/E/G ratio of 1.41 and a beta of 0.42. The business’s fifty day moving average price is $56.45 and its two-hundred day moving average price is $60.40. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.98. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. Amdocs’s revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.83 EPS. Analysts expect that Amdocs Limited will post 5.82 EPS for the current fiscal year.
Amdocs Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.5690 dividend. This represents a $2.28 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs’s payout ratio is presently 48.61%.
Hedge Funds Weigh In On Amdocs
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOX. Alpine Bank Wealth Management increased its holdings in Amdocs by 58.2% in the 3rd quarter. Alpine Bank Wealth Management now owns 500 shares of the technology company’s stock worth $29,000 after buying an additional 184 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Amdocs in the 3rd quarter valued at $57,000. Versant Capital Management Inc boosted its holdings in shares of Amdocs by 3,340.6% in the 3rd quarter. Versant Capital Management Inc now owns 1,101 shares of the technology company’s stock valued at $63,000 after acquiring an additional 1,069 shares during the last quarter. Rothschild Investment LLC increased its stake in shares of Amdocs by 296.2% in the third quarter. Rothschild Investment LLC now owns 1,240 shares of the technology company’s stock worth $71,000 after acquiring an additional 927 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Amdocs by 16.4% in the third quarter. Farther Finance Advisors LLC now owns 1,292 shares of the technology company’s stock worth $74,000 after acquiring an additional 182 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Analysts Set New Price Targets
DOX has been the topic of a number of recent research reports. Oppenheimer downgraded Amdocs from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Zacks Research lowered shares of Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday, November 9th. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Stifel Nicolaus cut their price objective on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Finally, Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 23rd. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $69.00.
Check Out Our Latest Research Report on Amdocs
Amdocs Company Profile
Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.
Recommended Stories
- Five stocks we like better than Amdocs
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
